Please use this identifier to cite or link to this item:
|Title:||Continuous renal replacement therapy: recent advances and future research.|
|Authors:||Prowle, John R;Bellomo, Rinaldo|
|Affiliation:||Department of Intensive Care, Austin Health, Heidelberg, Vic 3084, Australia|
|Citation:||Nature Reviews. Nephrology 2010; 6(9): 521-9|
|Abstract:||Continuous renal replacement therapy (CRRT) is the preferred treatment for acute kidney injury (AKI) in intensive care units (ICUs) throughout much of the developed world. Despite its widespread use, however, no formal proof exists that patient outcomes are improved when CRRT is used in preference to intermittent hemodialysis (IHD). In addition, controversy and center-specific practice variation in the clinical application of CRRT continues, owing to a lack of randomized multicenter studies of both CRRT and IHD providing level 1 data to inform clinical practice. Now, however, the publication of results from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network (ATN) study and the Randomized Evaluation of Normal versus Augmented Level Renal Replacement Therapy (RENAL) trial have provided an unparalleled quantity of information to guide clinicians. These pivotal trials investigated different intensities of CRRT in the ICU and provided level 1 evidence that effluent flow rates >25 ml/kg per hour do not improve outcomes in patients in the ICU. In this Review, we discuss the background and results of the ATN and RENAL trials and the emerging consensus that CRRT is the most appropriate treatment for AKI in vasopressor-dependent patients in the ICU. Finally, we describe the remaining controversies regarding the use of CRRT and the questions that remain to be answered.|
|Internal ID Number:||20644583|
|Subjects:||Acute Kidney Injury.therapy|
Intensive Care Units
Randomized Controlled Trials as Topic
Renal Replacement Therapy.trends
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.